
    
      The primary objective of the PFO Access Registry is to allow access to the AMPLATZER PFO
      Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes
      due to presumed paradoxical embolism through a patent foramen ovale and who have failed
      conventional drug therapy.
    
  